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Abstract
Background: The protozoan Giardia duodenalis is a common but highly diverse human parasite that comprises a
complex of seven morphologically identical genetic assemblages, further divided into sub-assemblages. There is
very little information available on the diversity of Giardia sub-assemblages and multi-locus genotypes infecting
people in the United Kingdom. In this study we studied the molecular epidemiology of Giardia in symptomatic
patients from North West England.
Methods: Whole faecal DNA was extracted from the faecal samples of 406 Giardia cases and the parasites
assemblage, sub-assemblage and multi-locus genotype were determined using PCR amplification, DNA sequencing
and phylogenetic analysis of the beta-giardin, glutamate dehydrogenase, triose-phosphate isomerase and
small-subunit ribosomal RNA genes. Information about age, gender and self-reported clinical outcomes was
also collected from the patients to check for differences associated with the infecting Giardia assemblage.
Results: Our results showed a difference in the age prevalence of the two assemblages, with assemblage A
being more common in older cases. Cases infected with assemblage B more often reported vomiting and a
longer illness than cases infected with assemblage A. The majority of infections (64 %) were caused by
assemblage B followed by assemblage A (33 %), while mixed-assemblage infections were rare (3 %).
Assemblage A isolates mostly belonged to the sub-assemblage AII and showed completed identity with
previously described isolates. The level of genetic sub-structuring was significantly higher in assemblage B
isolates, since a higher proportion of novel assemblage B sequences was detected compared to assemblage
A. A high number of assemblage B sequences showed heterogeneous nucleotide positions that prevented
the unambiguous assignment to a specific sub-assemblage. Both previously described and novel multi-locus
genotypes were described in both assemblages, and up to 17 different assemblage B multi-locus genotypes
were found.
Conclusions: We have produced the first data on the parasite multi-locus genotypes in the UK and have
demonstrated that the molecular diversity of Giardia is similar to other developed countries. Furthermore, we
showed that the parasite assemblages infecting humans may be associated with patients of different ages
and with different clinical outcomes.
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Background
Giardiasis is one of the most common parasitic gastro-
intestinal diseases in humans worldwide, and it is con-
sidered a neglected tropical disease [1]. It is caused by
the parasitic protozoan Giardia duodenalis, which is
transmitted either through contaminated water and
food or from person to person.
This parasite is a highly diverse organism and a com-
plex of at least seven morphologically identical genetic
assemblages (named A to G) that can infect a variety of
mammalian hosts [2]. The parasite assemblages are cur-
rently distinguished by polymerase chain reaction (PCR)
and DNA sequencing of genes such as the small-subunit
ribosomal RNA (ssu-rRNA), β-giardin (bg), glutamate
dehydrogenase (gdh) and triose-phosphate isomerase
(tpi) genes. There is increasing phenotypic and molecu-
lar evidence that these assemblages actually represent
distinct species, and a new nomenclature using species
names has been advocated [3]. Humans are infected by
parasites belonging to assemblage A (G. duodenalis) and
B (G. enterica), and the latter is usually the most preva-
lent in human populations [4].
There is extensive genetic sub-structuring within assem-
blage A and B, and parasites are further differentiated by
sequence data from multiple loci into at least five so-
called sub-assemblages (named AI-III and BIII-IV) [2]. A
multi-locus sequence typing (MLST) approach and no-
menclature based on the use of three genes (bg, gdh and
tpi) has been proposed for assemblage A isolates [5].
However, assemblage B parasites show a considerably
higher genetic variability and their unambiguous classifi-
cation in sub-assemblages and sub-types is partially ham-
pered by the frequent occurrence of DNA sequences with
overlapping nucleotides (e.g. the presence of two possible
nucleotides at one particular position in the sequence).
So far only a few studies have applied the MLST proto-
col to genotype Giardia from humans [5–7], and more
data are needed on the distribution and diversity of multi-
locus genotypes of Giardia in developed countries.
In particular, very little information is available on the
assemblage and sub-assemblage diversity of Giardia in
people from the United Kingdom. Previous studies have
included only a relatively small number of patients, and
have relied on the use of a single locus for parasite geno-
typing. Using restriction fragment length polymorphism
analysis of the tpi gene assemblage B was found in 63.6 %
of 33 Giardia patients from London, followed by assem-
blage A (27.3 %) and mixed-assemblage infections (9.1 %)
[8]. Another study on symptomatic cases in London found
a prevalence of 24, 73 and 3 % for Giardia assemblage A,
B and mixed infections respectively by DNA sequencing
of the tpi and ssu-rRNA genes [9]. A very similar picture
has been reported more recently using a real-time tpi PCR
assay on specimens from patients in England and Wales:
assemblage B accounted for 72 % of the infections
whereas mixed infections were very rare (3 %) [10]. Only
two studies determined the Giardia sub-assemblage based
on the sequencing of the tpi locus [8, 9]: all assemblage A
parasites were AII, whereas both BIII and BIV sub-
assemblages were identified in assemblage B isolates.
No study from the UK so far has investigated the mo-
lecular diversity of Giardia parasites in a large number
of patients using a multi-locus sequence typing ap-
proach. Here we report the first data on the prevalence
and diversity of Giardia assemblages, sub-assemblages
and multi-locus genotypes in symptomatic patients
with giardiasis from North West England, determined
using the MLST protocol based on the sequencing of
the bg, gdh and tpi loci.
Methods
Faecal specimen collection and DNA extraction
Faecal specimens were collected between January 2008
and August 2013 from patients with symptomatic giardia-
sis diagnosed by the microbiology laboratories of three
hospitals in North West England: the Royal Preston
Hospital serving the population of Central Lancashire),
the Royal Blackburn Hospital serving East Lancashire and
the Manchester Royal Infirmary serving the (Greater
Manchester area. In all three laboratories all the faecal
samples from diarrhoeic patients submitted by general
practitioners are routinely tested for Giardia. Diagnosis at
all laboratories was made using first an antigen detec-
tion method for the simultaneous detection of Giardia
and Cryptosporidium (GIARDIA/CRYPTOSPORIDIUM
CHEK®, Techlab) followed by confirmation of Giardia
infection with an immunochromatographic assay
(RIDA®QUICK Giardia, R-Biopharm). Specimens were
also examined for Cryptosporidium, Campylobacter,
Salmonella, Shigella, Escherichia coli O157 and Vibrio
spp. when indicated, and patients found to be co-
infected with one of these pathogens were excluded. In-
formation about the patients’ gender, age, experienced
symptoms and history of travel was collected via a
questionnaire. Faecal specimens were stored unpre-
served at 4 °C before DNA extraction. Due to logistical
constraints samples collected from 2008 to 2010 were
extracted in 2011 whereas samples collected in 2011
were extracted regularly within one month from collec-
tion. Whole faecal DNA was extracted directly from
the specimens using a commercial kit (QIAamp® DNA
Stool Mini Kit, QIAGEN Ltd.) following the manufac-
turer’s instructions with only minor modifications: in
the first lysis step the samples were heated for 10 min
at 95 °C (instead of 5 min at 70 °C as per the manufac-
turer’s instructions). The DNA was eluted in 100 μl of
elution buffer and stored at −20 °C.
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Giardia multi-locus genotyping and phylogenetic analysis
Extracted DNA was used to amplify the Giardia beta-
giardin (bg), glutamate dehydrogenase (gdh) and triose-
phosphate isomerase (tpi) genes. For the bg gene, the
753 bp fragment of the gene was first amplified using the
primers G7 (5′-AAGCCCGACGACCTCACCCGCAGT
GC-3′) and G759 (5′-GAGGCCGCCCTGGATCTTCG
AGACGAC-3′) [11], from which the 511 bp fragment was
then amplified with the BGf (5′-GAACGAACGAGATC
GAGGTCCG-3′) and BGr (5′-CTCGACGAGCTTCGT
GTT-3′) [12]. For the gdh gene, a 754 bp fragment of the
gene was first amplified using the primers GDH1 (5′- T
TCCGTRTYCAGTACAACTC-3′) and GDH2 (5′-ACC
TCGTTCTGRGTGGCGCA-3′), followed by the amplifi-
cation of a 530 bp fragment with the GDH3 (5′- ATGAC
YGAGCTYCAGAGGCACGT-3′) and GDH4 (5′- GTGG
CGCARGGCATGATGCA-3′) primers [5]. Two Giardia
assemblage-specific nested PCR assays were used to amp-
lify the tpi gene. A 605 bp fragment of the gene was first
amplified using the AL3543 (5′-AAATIATGCCTGCTC
GTCG-3′) and AL3546 (5′-CAAACCTTITCCGCAAAC
C-3′) primers [13]. Then the PCR products were used in
two separate reactions, one involving the amplification of
a 332 bp fragment of the gene from assemblage A using
the Af (5′- CGCCGTACACCTGTCA-3′) and Ar (5′- AG
CAATGACAACCTCCTTCC-3′) primers [14], and the
other amplifying a 400 bp fragment from assemblage B
with the primers Bf (5′- GTTGTTGTTGCTCCCTCC
TTT-3′) and Br (5′-CCGGCTCATAGGCAATTACA-3′)
[6]. In order to ensure the assemblage typing of most of
the isolates, samples that failed to amplify at the bg, gdh or
tpi loci were further amplified for the 292 bp fragment of
the ssu-rRNA gene using the primers RH11 (5′-CATCC
GGTCGATCCTGCC-3′) and RH4 (5′- AGTCGAACCC
TGATTCTCCGCCAGG-3′) [15].
All PCR reactions were prepared in a final volume of
25 μl containing 2.5 units of Taq DNA polymerase and
1× buffer (containing Tris-Cl, KCl, (NH4)2SO4 and
15 mM MgCl2, pH 8.7) (QIAGEN
®), 200 μM of each
deoxynucleotide (Sigma-Aldrich®), 250 nM of each pri-
mer, nuclease-free water and genomic DNA (2 μl in
first step reactions and 1 μl of first reaction product in
the nested reactions). Positive (genomic DNA from G.
duodenalis assemblage A isolate WBC6 trophozoites
and from an assemblage B confirmed clinical isolate)
and negative (nuclease-free water) control samples
were included in each reaction. Reactions were per-
formed using a DNA Engine Dyad® Peltier Thermal
Cycler (MJ Research Inc.). All PCR reactions included
a first denaturation step at 94 °C for 3 min, followed by
35 cycles each including denaturation at 94 °C for 20 s,
annealing for either 30 s (bg gene: 65 and 64 °C for the
primary and nested reaction, respectively; gdh gene: 58
and 68 °C for the primary and nested reaction,
respectively; ssu-rRNA gene: 59 °C) or 45 s (tpi gene:
58, 68 and 62 °C for the primary reaction and the
assemblage A- and B-specific secondary reactions, re-
spectively) and extension at 72 °C for 1 min. All reac-
tions were concluded by a final extension step at 72 °C
for 10 min. Successful amplification was verified by
running 5 μl of PCR products onto a 1.5 % agarose gel
stained with SYBR® Safe DNA gel stain (Invitrogen™).
PCR products were purified using the QIAquick® PCR
Purification kit (QIAGEN Ltd.), and they were se-
quenced in both directions using the respective for-
ward and reverse primers with an Applied Biosystems®
3730 DNA Analyser at the Core Genomic Facility,
Medical School, University of Sheffield, UK. The chro-
matograms were analysed and the sequences edited
using BioEdit (version 7.0.9). Sequences were then
compared to homologous sequences (>99 % similarity)
in GenBank using the Basic Local Alignment Search
Tool (BLAST) (http://blast.ncbi.nlm.nih.gov/Blast.cgi)
to determine the Giardia assemblage, sub-assemblage
and sub-type. Maximum likelihood (ML) phylogenetic
trees were built using the Molecular Evolutionary
Genetics Analysis (MEGA) program ver. 6.06 (Tamura
et al., 2013) after determining the optimal nucleotide
substitution model. Sequences without overlapping
nucleotide positions were aligned in MEGA with repre-
sentative sequences from the major G. duodenalis sub-
assemblages AI-III and BIII-IV downloaded from
GenBank. Also representative sequences from the ani-
mal assemblages (C-G) and other species of Giardia
(either G. muris or G. ardeae depending on the
availability of a sequence of the gene examined) were
included. The full list of the reference sequences used
in the phylogenetic analysis is reported in the
Additional file 1.
Statistical analysis
Statistical analysis was performed using SPSS® Statistics 20
(IBM, USA). Tests of significance included the Pearson’s
Chi-Square test (or Fisher’s Exact test for sparse data) and
the Mann-Whitney’s U test(s) for categorical and continu-
ous variables, respectively. Statistical significance was set
as a p-value <5 %.
Ethics, consent and permissions
Ethical approval for the use of the patients faecal samples
and questionnaire information was obtained through the
National Research Ethics Service, Committee North West,
Lancaster under the following two names: Molecular
typing of human Giardia isolates v3.2(REC reference 10/
H1015/79) and Case–control study of risk factors for
giardiasis in North West England (REC reference 11/NW/
0704).
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Results
PCR amplification success and assemblages prevalence
During the study period a total of 406 faecal specimens
from patients with confirmed giardiasis were collected
and extracted, and 218 (54 %) successfully amplified at
least one of the three MLST genes tested. The tpi as-
semblage A/B-specific product amplified in 188 of these
samples (86.2 %), followed by the bg gene in 166
(76.1 %) and the gdh gene in 153 (70.2 %). Of the 188
negative specimens that were further amplified for the
ssu-rRNA gene, 77 (41 %) amplified for this locus
whereas 111 (59 %) were negative. By considering the
amplification of the four loci tested, 295 samples out of
the 406 extracted (73 %) successfully amplified at least
one of them. The overall PCR amplification success of
the samples varied accordingly to the year of collection
and the time from collection to DNA extraction. Speci-
mens collected in 2012 and 2013 that were extracted
within one month showed a higher amplification suc-
cess rate (169 positives/199 tested, 85 %) compared
with specimens from 2011 extracted between two and
eight months (41/57, 72 %) and specimens from 2008
to 2010 that were stored unpreserved at 4 °C for more
than one year before extraction (85/150, 57 %).
The Giardia assemblage was successfully determined
from 247 specimens by either DNA sequencing (239
specimens) or on-gel visualization of the tpi assemblage-
specific products (eight specimens for which DNA se-
quencing failed): assemblage B was found in the majority
of the specimens (64 %, n = 158), followed by assemblage
A (33 %, n = 82) and mixed-assemblage infections (3 %,
n = 7). Of the seven specimens showing a mixed infec-
tion three were diagnosed by the tpi assemblage-specific
PCR (whereas they were typed as B at both the bg and
gdh loci), three were typed as B at the tpi locus but as A
at the gdh locus (two specimens) or at the bg locus (one
specimen), and one was typed as A at the bg locus but
as B at the gdh locus.
Socio-demographics, clinical and travel history of
assemblage A and B patients
The two assemblages did not differ in their gender dis-
tribution (Pearson’s χ2, p = 0.494), but assemblage A
cases had a significantly higher age (48.5 years, range
11 months-94) compared to B cases (38 years, range
1–79) (Mann-Whitney’s U test, p = 0.007): this was
due to an excess of assemblage B infections in adults from
20 to 50 years of age compared with an excess of assem-
blage A infections in the elderly (70+ years) (Fig. 1).
The experienced symptoms and travel history of as-
semblage A and B patients are shown in Table 1.
Patients with assemblage B infection reported vomiting
significantly more often and longer illness duration
compared with patients with assemblage A infection,
whereas the opposite was seen for the presence of
blood in stools. Although the frequency of overseas
travel among patients with the two assemblages was
similar, the majority of patients who visited countries
more at-risk for giardiasis (e.g. Asia and Middle East,
Africa and Latin America) were infected with assemblage
B whereas those visiting countries not at-risk were mostly
infected with assemblage A. Destinations reported by the
21 assemblage B patients included mostly India and
Pakistan (47.6 %, ten patients), followed by South-East
Asia (14.3 %, three) and Egypt (9.5 %, two).
Giardia sub-assemblages and subtypes at the bg, gdh and
tpi loci
The phylogenetic trees based on the successfully se-
quenced and unambiguously identified bg, gdh and tpi loci
are shown in the Additional file 2. No intra-assemblage
variation was observed in the 34 samples that were se-
quenced at the ssu-rDNA locus so these results are not
presented. A list for the sequences that showed novel nu-
cleotide substitutions or overlapping nucleotides at any
positions are shown in Additional file 3.
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Fig. 1 Infecting Giardia assemblage and age in 240 case-patients successfully genotyped and with a single-assemblage infection. The raw number
of patients is reported above the bars
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Assemblage A
At the bg locus, the majority of 42 isolates successfully
and unambiguously identified showed complete se-
quence identity with the two previously described sub-
assemblage AII subtypes A2 (16 isolates) and A3 (23),
whereas one isolate had a sequence identical to the
sub-assemblage AI reference. Two isolates (13/C146,
10/H12) showed a novel nucleotide substitution com-
pared with the AII and AI references respectively, and
three isolates showed overlapping nucleotides along the
bg sequence.
At the gdh locus, of the 49 assemblage A isolates suc-
cessfully identified the sequence of 27 isolates was iden-
tical to the sub-assemblage AII reference, whereas 18
and three isolates matched the two previously described
sub-assemblage AII human isolates ECUST2196 and
ISSGd198, respectively. The sequence of one isolate
(12/C41) showed a novel substitution compared with
the ECUST2196 isolate sequence, and two other iso-
lates showed overlapping nucleotides at one position
along the gdh sequence.
At the tpi locus, 50 successfully identified assemblage
A isolates showed complete sequence identity with the
sequence of the sub-assemblage AII reference, whereas
one isolate showed a sequence identical to a previously
described AI-type dog isolate (Martha). No tpi se-
quences with novel substitutions or overlapping nucleo-
tides at any position were observed.
Assemblage B
At the bg locus, 16 different subtypes were identified in
89 unambiguously identified assemblage B. The majority
(70 isolates) had sequences identical to those of five pre-
viously reported subtypes named B1 from humans: the
most represented subtype was B1–3 (48 isolates),
followed by B1–2 (11), B1–5 (six), B1–1 (three) and B1
(one). The sequence of seven isolates showed complete
identity with the BIII reference sequence. One isolate
was identical to the sub-assemblage BIV reference se-
quence, and two isolates showed complete identity with
two previously described BIV-type isolates (Sweh198 and
GU417). The sequences of six isolates were identical to
those of three previously described subtypes from
humans, namely BG-Ber2 (four), BG-Ber1 and BG-Ber6
(one each). Four isolates showed novel nucleotide substi-
tutions in the bg sequence and 18 had overlapping nu-
cleotides at multiple positions along the sequence.
At the gdh locus, 13 different subtypes were observed
amongst the 69 isolates unambiguously identified. The
majority (45 isolates) had a sequence that was identical
to the reference BIV subtype. The sequence of 13 and
two isolates matched the sequence of two previously
described human (ISSGd167) and primate (Ad-158)
isolates, respectively. Nine isolates showed novel substi-
tutions (from two up to eight) in their gdh sequence,
and 25 had overlapping nucleotides at multiple posi-
tions along the sequence.
In 86 isolates successfully sequenced and identified at
the tpi locus, 13 different subtypes were found. The ma-
jority (50 isolates) had a sequence identical to the refer-
ence BIV, followed by 13 isolates where the sequence
was identical to the sequence of the previously described
BIV-type human isolate VB906855. A total of eleven iso-
lates were identical to the sub-assemblage BIII reference
subtype. Three isolates were identical to three BIII–type
human isolates previously described (HS29, Sweh060
and HS114) and a further two isolates showed complete
sequence identity with another previously described
Table 1 Clinical and travel history of patients with Giardia assemblage A or B infection
Assemblage n (%)**
Variable No.* A B p-value
Diarrhoea 141 49 (96.1) 89 (98.9) 0.296
Blood in stools 129 5 (11.1) 1 (1.2) 0.019
Vomiting 130 18 (40) 52 (61.2) 0.027
Abdominal
pain (cramps)
135 34 (71) 69 (79) 0.268
Fever 126 19 (45.2) 40 (48) 0.801
Median length of illness in days (range),
in patients no longer ill when contacted
72 10 (1–50) 18 (4–73) 0.019
Admitted to hospital due to illness 133 8 (16.3) 5 (6) 0.070
Travel abroad (outside UK) 142 16 (31.4) 23 (25.3) 0.435
Travel abroad to
at-risk destinations
No travel abroad 142 35 (68.6) 68 (74.7) <0.001
Abroad, not at-risk destination 11 (21.6)*** 2 (2.2)***
Abroad, at-risk destination~ 5 (9.8)*** 21 (23.1)***
*number of participants that answered the question; **number of A and B patients with percentages calculated relative to those that answered the question;
~ including Asia and Middle East (with Turkey), Africa, Central and South America; ***proportions differing significantly from each other with p < 0.05
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human isolate (Sweh171). Six isolates showed novel sub-
stitutions in their tpi sequence, and 24 had overlapping
nucleotides at multiple positions along the sequence.
Giardia multi-locus genotypes (MLGs) and household
clusters
In total, 30 assemblage A and 45 assemblage B isolates
were successfully and unambiguously genotyped at all
the three MLST loci (Table 2). All assemblage A MLGs
belonged to the sub-assemblage AII. Two previously
identified MLGs (AII-1 and AII-2) were found in nine
and four isolates respectively, and also four novel MLGs
were identified. Three isolates genotyped at all the loci
showed overlapping nucleotides in at least one sequence:
one showed a potentially mixed AII-1/AII-2 MLG
whereas the other two were not clearly identifiable. Re-
garding the assemblage B isolates, a higher diversity of
MLGs was observed. With the exception of two previ-
ously identified MLGs (1 and 7) found in 21 (46.7 %)
and one isolates, 15 novel assemblage B MLGs were
identified showing different combinations of sequences
at the three loci.
Of the 13 patients that were part of five distinct house-
hold clusters identified, 12 had the infecting Giardia as-
semblage successfully determined. Assemblage A was
found in two clusters. In one cluster where two family
members were successfully genotyped the Giardia MLG
causing infection was the same. Assemblage B was found
in three clusters. In a cluster involving four people from
whom the parasite MLG was determined the same MLG
was found in all the cases.
Discussion
We have characterized for the first time the molecular
diversity of Giardia from a large number of symptomatic
patients in North West England and we have found im-
portant differences in the age distribution and clinical
outcome of infection between the parasite assemblage A
and B.
The two assemblages differed in their age distribution
in our sample with a higher prevalence of assemblage B
in adults in their 30s and 40s and a predominance of
assemblage A in older people. The difference between
the two assemblages, in particular, was almost entirely
Table 2 Giardia multi-locus genotypes of 76 isolates unambiguously genotyped at the bg, gdh and tpi loci
Assemblage No. isolates (ID) Bg Gdh Tpi MLG
A 9 A2 AII AII AII-1a
4 A3 AII AII AII-2a
9 (9/10, 11/29, 11/67, 12/C65, 12/C70,
12/C74, 13/C117, 13/C122, 13/C162)
A3 ECUST2196 AII AII new (a)
5 (8/H3, 11/27, 12/C16, 12/G, 13/C123) A2 ECUST2196 AII AII new (b)
2 (12/C31, 13/C164) A3 ISSGd198 AII AII new (c)
12/C41 A2 12/C41~ AII AII new (d)
B 21 B1–3 BIV BIV 1b
1 B1–1 BIV BIV 7b
3 (12/C7, 13/C147, 13/CF) B1–2 BIV BIV B new (a)
3 (12/C87, 12/C92, 12/C96) B1–5 BIV VB906855 B new (b)
3 (13/C152, 13/C165, 13/CE) B1–5 ISSGd167 VB906855 B new (c)
2 (12/C9, 12/C84) B1–2 BIV VB906855 B new (d)
2 (12/C80, 12/C160) B1–2 ISSGd167 BIV B new (e)
12/C95 B1–1 ISSGd167 BIV B new (f)
13/CO 13/CO~ BIV BIV B new (g)
13/C149 B1–2 Ad-158 Sweh171 B new (h)
13/C145 B1–2 Ad-158 VB906855 B new (i)
13/C155 B1–3 13/C155 BIV B new (l)
12/C83 B1–3 ISSGd167 BIV B new (m)
11/28 B1 ISSGd167 BIV B new (n)
10/28 BIII 10/28~ VB906855 B new (o)
12/C20 BIII BIV BIV B new (p)
12/C19 12/C19~ 12/C19~ BIII B new (q)
The isolates showing a novel MLG are specified by their identifier code (ID). ~ new sequence; asame MLG reported by [5]; bsame MLG reported by [7]
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concentrated in patients 70 years old or older, which
showed an excess of assemblage A occurrence. The
prevalence of Giardia assemblages in relation to the
age of the patients has not been investigated thoroughly
before, so we cannot compare directly our results with
those from other studies. Although both assemblages
showed a bimodal age distribution in a previous study
in the UK [9], assemblage B was more prevalent than A
in children and adults in their 30s, whereas the oppos-
ite was seen in people in their forties and particularly in
the elderly (60+ years of age). These results were simi-
lar to what we have observed in our sample. The pres-
ence of age-related differences in the exposure to a
particular assemblage or immunity to a particular para-
site type could both be responsible for the observed
pattern, but more studies are needed to test these
hypotheses.
We also found differences in the self-reported clinical
outcomes of infection between cases infected with the
two assemblages. Vomiting was reported more fre-
quently by the cases infected with assemblage B, who
also reported a longer duration of illness compared to
cases infected with assemblage A. Interestingly, there
were no differences in relation to the reporting of other
symptoms such as abdominal pain or fever. Whether
these symptoms represent a general feature of infection
due to similarities between the assemblages in term of
host-parasite interactions, is an issue that needs further
investigation. Overall our results suggest that infection
with assemblage B may be associated with a more severe
illness. In children from Cuba assemblage B was associ-
ated with a higher frequency of diarrhoea, flatulence and
abdominal pain [16], and an association between assem-
blage B infection and flatulence was also observed in
children from Sweden [7]. Only symptomatic cases of in-
fection were included in our study. If assemblage B
causes a more severe illness in humans, people infected
with this assemblage will attend their general practi-
tioner more frequently and they will then represent the
majority of notified cases. This may explain the higher
prevalence of assemblage B infections compared to those
caused by assemblage A observed in symptomatic pa-
tients from the UK and other developed countries [2, 4].
More data are needed to determine whether assemblage
A commonly occurs in people that are asymptomatic or
show a relatively mild symptomatology in developed
countries like the UK, as this has been reported in a few
occasions from other places like Ethiopia [17], Saudi
Arabia [18] and Cuba [16].
Interestingly, hospitalisation and the presence of
blood in the stools were reported more frequently by
assemblage A cases. This finding was probably due to
an effect of age: overall assemblage A cases were older
than B cases, and cases reporting blood in stools and
hospitalisation were also older than those not reporting
these two outcomes.
Another interesting finding was that the majority of
cases with a history of travel to developing countries
were infected with assemblage B. To the best of our
knowledge, this is a new finding and the reasons behind
such patterns require further investigation. It may be
possible that due to the fact that Giardia assemblage B
is considered to have a mostly human reservoir, the ex-
posure to environments that are heavily contaminated
with human faeces as in developing countries settings
may lead to a higher proportion of infections with this
particular assemblage in travellers.
The combined use of four different loci allowed the
successful PCR amplification in more than 70 % of the
extracted specimens. In particular, the use of the ssu-
rRNA locus ensured the amplification in specimens that
were negative at the bg, gdh and tpi loci. The small-
subunit ribosomal RNA gene usually shows a high suc-
cess of PCR amplification due to its multi-copy nature,
particularly in specimens (like faeces or environmental
samples) with a low quantity of target DNA or a higher
quantity of PCR inhibitors [19].
The differential amplification success we observed at
the MLST loci has been commonly reported in studies
using the same primers, although results vary. The amp-
lification success rate reported by a study on symptom-
atic patients from Germany was 92.4 % for the bg, 44 %
for the tpi and only 25.7 % for the gdh locus [20]. Failure
of amplification of assemblage B at multiple loci includ-
ing those used in our study was also extensively ob-
served in dog samples [21]. It has been proposed that
the lack of amplification of particular loci could be due
to the presence of nucleotide mismatches between the
PCR primers and the genomic sequences [20], leading to
the inability of certain primers to amplify particular sub-
genotypes as suggested for the bg primers in respect to
particular assemblage B sub-types [22]. We checked for
the presence of PCR inhibition by spiking a subset of
negative samples with Giardia DNA and re-amplifying
them for the ssu-rRNA and bg loci, and they all success-
fully amplified. It has to be noted that our specimens
originated from patients in whom Giardia infection was
only confirmed using the commercially available enzyme-
linked immunoassay method GIARDIA/ CRYPTOSPOR
IDIUM CHEK®. It has been shown that this assay detects
the presence of a soluble antigen that is released in large
quantities during the encystation of Giardia trophozoites
in vitro [23]. It may be possible that in some of the speci-
mens only the soluble antigen but not parasite cysts were
present, resulting in the absence of Giardia DNA available
for PCR amplification. Also the time passed from sample
collection to DNA extraction negatively influenced the
amplification success in the specimens, particularly those
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that were stored unpreserved for several months or even
years before being extracted. This effect was likely due to
the degradation of cysts and parasite DNA over time.
In terms of the prevalence and molecular diversity of
the parasites, we found that assemblage B was respon-
sible for the majority of infections. Our findings match
those reported from symptomatic patients from Europe
[6, 7, 20] and confirmed the prevalence data that has
been previously published from the UK [8–10].
The molecular diversity of assemblage A isolates at
the sub-assemblage level was successfully characterised
in the majority of cases. Sequences with heterogeneous
positions were observed only in a small proportion of
isolates (and they were mostly observed at the bg
locus), confirming the rare occurrence of sequences
with overlapping nucleotides consistently reported in
assemblage A parasites [4]. Regardless of the gene ana-
lysed, the vast majority of the sequences matched those
of previously described isolates and sequences showing
novel polymorphisms were observed in very few cases.
Most of the assemblage A isolates were assigned to the
sub-assemblage AII consistently across the three loci,
confirming the preponderance of this sub-assemblage
in humans compared to sub-assemblage AI as previ-
ously shown in other studies using multi-locus se-
quence typing [5–7].
The degree of variability (e.g. the number of different
sub-types identified) differed between the loci and
showed remarkable similarities with previous studies. At
the bg locus the subtype A3 was found in the majority of
isolates, as reported from symptomatic patients in
Belgium [6] and Germany [20]. Two subtypes were
found at the gdh locus, with AII being the most frequent
as observed in both Belgium [6] Sweden [7], whereas
only one AII subtype was identified at the tpi locus. The
multi-locus analysis revealed that several patients were
infected with two previously described sub-assemblage
AII MLGs (AII-1 and AII-2), which have been previously
reported in symptomatic patients from Italy [5], Belgium
[6] and Sweden [7]. As reported in the aforementioned
studies, we also observed MLGs showing different com-
binations of bg, gdh and tpi subtypes that have never
been reported before. These results suggest that humans
can be infected with an array of very diverse assemblage
A genotypes, and that the MLST approach should be
consistently used in all future molecular epidemiological
studies in other geographical regions.
The molecular analysis of assemblage B isolates was
complicated by the high frequency of occurrence of se-
quences with heterogeneous positions, with overlapping
nucleotides observed on average in 20 % of the se-
quences across the three loci. A few assemblage B
isolates showing heterogeneous templates potentially
represented mixed sub-assemblage infections but the
identification could not be unequivocally resolved. Het-
erogeneous sequences are a common occurrence in as-
semblage B parasites [4, 20], and their presence has
been observed following DNA extraction and sequen-
cing even from single Giardia cysts and between differ-
ent cysts isolated from the same patient [24]. Other
than mixed sub-assemblage infections, the occurrence
of heterogeneous sequences may be due to the presence
in Giardia of two nuclei, which are thought to accumu-
late mutations and evolve separately leading to allele
sequence heterozygosity (e.g. the appearance of nucleo-
tidic differences in the sequence between alleles of the
same gene) [25]. The overall level of allele sequence
heterozygosity has been estimated to be significantly
higher in the genome of Giardia assemblage B com-
pared with A [26], which can account for the higher oc-
currence of heterogeneous sequences observed in the
former compared to the latter. The assignment to a
particular sub-assemblage of isolates was not immedi-
ate also due to discrepancies between the different
markers. At the bg locus the majority of the isolates
belonged to subtypes that were part of the previously
identified B1 group [6], as it has also been observed in
human isolates from Sweden [7]. The B1 group clus-
tered nearby the sub-assemblage BIII by phylogenetic
analysis, but whether it represents an actual sub-
assemblage other than BIII and BIV has to be verified.
Conversely, the analysis of the gdh and tpi markers
assigned the majority of isolates to the sub-assemblage
BIV. The genotypic diversity observed in assemblage B
isolates was much higher compared with the one ob-
served within assemblage A, consisting in 21 novel sub-
types (the majority of which at the gdh and tpi loci).
Similar levels of diversity at the three markers were
reported in assemblage B parasites in patients from
Europe [7, 20]. There is still a lack of information about
the level of genetic differentiation within Giardia as-
semblage B, and the classification in sub-assemblages
can be complicated by the use of an imprecise termin-
ology in naming parasite isolates [25], since the term
sub-assemblage is commonly used to indicate nucleoti-
dic variants that should be more appropriately referred
to sub-types (within a sub-assemblage).
Interestingly, following multi-locus analysis of isolates
successfully characterised at all the three markers we
found the majority of patients being infected with one
MLG previously reported in the majority of patients of a
study in Sweden [7]. Similarly to what was observed for
assemblage A, we also observed a high number of novel
assemblage B MLGs showing different combinations of
bg, gdh and tpi subtypes.
Our results confirmed the need for a novel DNA
sequence-based classification system applicable for the
genotyping of Giardia parasites below the assemblage
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level. Although the use of the bg, gdh and tpi loci seems
to produce relatively consistent typing results for assem-
blage A sub-assemblages (supported by both phylogen-
etic and multi-locus analysis), it is clearly limited in its
applicability for the assemblage B sub-typing. The ex-
tremely high sequence variation observed in assemblage
B parasites (often involving a single nucleotidic differ-
ence between isolates) and the poor resolution of phylo-
genetic analyses complicate enormously the assignment
of isolates to a specific sub-assemblage. The sub-groups
BIII and BIV originally identified using allozyme electro-
phoresis are not supported by DNA sequence analysis
[4]. The existence of several sub-assemblages within B
(as suggested by the high levels of genetic variation)
should then be re-evaluated following a more compre-
hensive biochemical and genetic characterization, in
order to determine whether these subgroups are consist-
ent and discrete. The use of next generation sequencing
(NGS) technologies would be of great help in determin-
ing the extent of genetic sub-structuring within assem-
blages at a whole-genome level and in identifying either
genes that are less affected by allele sequence heterozy-
gosity or genes that are unique to particular sub-
assemblages [25]. Such approach has been recently used
to compare the genomes of two Giardia assemblage B
isolates, leading to the identification of up to 70 poly-
morphic genes for potential use in sub-assemblage geno-
typing [27]. These genes could then be incorporated in
multiplex real-time PCR assays allowing the sensitive and
univocal identification of assemblage B sub-assemblages
in faecal DNA samples.
Conclusions
This study has shown that the molecular diversity of Giar-
dia in symptomatic patients from North West England is
largely similar to other areas of Europe, and that the two
assemblages may differ in their distribution amongst
people of different ages and in the illness they cause. The
majority of infections were caused by assemblage B alone,
followed by infections with sub-assemblage AII. Molecular
analysis at both the single-locus and multi-locus level re-
vealed the occurrence of both novel and already described
sub-types, with assemblage B parasites showing a signifi-
cantly higher diversity compared with assemblage A para-
sites. We have also generated the first data on the parasite
multi-locus genotypes for the UK, showing the presence
of both already described and novel genotypes. The unam-
biguous genotyping of a large number of assemblage B
isolates was prevented by the high frequency of heteroge-
neous sequences. There is an urgent need for the develop-
ment of novel and more robust genetic markers for this
group of parasites to be incorporated into a reliable multi-
locus genotyping method. The use of multi-locus
sequence typing may help in the future to identify infec-
tion sources and the dynamics of spread in household
clusters.
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